Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Debt / NOTE 1.250% 5/1
-
Market price (% of par)
-
95.0%
-
Total 13F principal
-
$547,434,225
-
Principal change
-
+$31,836,711
-
Total reported market value
-
$521,865,010
-
Number of holders
-
58
-
Value change
-
+$30,701,081
-
Number of buys
-
24
-
Number of sells
-
28
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q3 2025
As of 30 Sep 2025,
BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 was held by
58 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$547,434,225
in principal (par value) of the bond.
The largest 10 bondholders included
TENOR CAPITAL MANAGEMENT Co., L.P., Voya Investment Management LLC, BlackRock, Inc., MACKAY SHIELDS LLC, Opti Capital Management, LP, CAPSTONE INVESTMENT ADVISORS, LLC, Wellesley Asset Management, MILLENNIUM MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
58
institutional bondholders reporting positions
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.